Comparison of Intermittent Fasting and Caloric Deficit for Weight Loss in Women With Polycystic Ovarian Syndrome
Primary Purpose
Polycystic Ovarian Syndrome, Weight Loss, Intermittent Fasting
Status
Completed
Phase
Not Applicable
Locations
Pakistan
Study Type
Interventional
Intervention
intermittent fasting
Caloric restriction
Sponsored by
About this trial
This is an interventional treatment trial for Polycystic Ovarian Syndrome
Eligibility Criteria
Inclusion Criteria:
- PCOS as described by Rotterdam's criteria
Exclusion Criteria:
- endocrine disorders
- diabetic
- hypertensive
- Taking medications affecting weight or energy intake/energy expenditure in the last 6 months, including weight loss medications, antipsychotic drugs or other medications as determined by the study physician;
- The body weight fluctuated more than 5% in recent 3 months.
- Liver and kidney dysfunction: renal impairment, creatinine clearance rate < 30 mL/min/1.73 m2, transaminase increased, more than three times higher than the normal limit;
- History of serious cardiovascular or cerebrovascular disease (angina, myocardial infarction or stroke) in the past 6 months;
- History of thyroid diseases;
- pregnant
- Currently participating in weight loss programs or weight change in the past 3 months (> 5% current body weight)
- Patients who cannot be followed for 16 months (due to a health situation or migration)
- Patients who are unwilling or unable to give informed consent
Sites / Locations
- Aziz Medical Center
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
intermittent fasting
caloric restriction
Arm Description
Daily caloric requirement was calculated using basal metabolic rate (BMR) calculator. All women were directed to decrease calorie intake by 500 calories. Women were told about timed restricted feeding. They were required to fast for 16 hours and consume their allotted calories during the remaining 8 hours.
Daily caloric requirement was calculated using basal metabolic rate (BMR) calculator. All women were directed to decrease calorie intake by 500 calories.
Outcomes
Primary Outcome Measures
weight loss in kg
Secondary Outcome Measures
decrease in body fat percentage
fasting plasma insulin
blood pressure in mm Hg
Full Information
NCT ID
NCT04452968
First Posted
June 26, 2020
Last Updated
November 23, 2020
Sponsor
Karachi Medical and Dental College
Collaborators
Aziz Medical Center
1. Study Identification
Unique Protocol Identification Number
NCT04452968
Brief Title
Comparison of Intermittent Fasting and Caloric Deficit for Weight Loss in Women With Polycystic Ovarian Syndrome
Official Title
Intermittent Fasting and Polycystic Ovarian Syndrome
Study Type
Interventional
2. Study Status
Record Verification Date
November 2020
Overall Recruitment Status
Completed
Study Start Date
July 1, 2020 (Actual)
Primary Completion Date
October 30, 2020 (Actual)
Study Completion Date
October 30, 2020 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Karachi Medical and Dental College
Collaborators
Aziz Medical Center
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Time restricted feeding (TRF) has been emerging as a potential weight loss strategy that avoids major dietary changes but achieves strong effects. It also improves insulin sensitivity through increased human growth hormone. This effect helps to improve the root cause of weight gain and has additional benefits for women with PCOS.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Polycystic Ovarian Syndrome, Weight Loss, Intermittent Fasting
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
96 (Actual)
8. Arms, Groups, and Interventions
Arm Title
intermittent fasting
Arm Type
Experimental
Arm Description
Daily caloric requirement was calculated using basal metabolic rate (BMR) calculator. All women were directed to decrease calorie intake by 500 calories.
Women were told about timed restricted feeding. They were required to fast for 16 hours and consume their allotted calories during the remaining 8 hours.
Arm Title
caloric restriction
Arm Type
Active Comparator
Arm Description
Daily caloric requirement was calculated using basal metabolic rate (BMR) calculator. All women were directed to decrease calorie intake by 500 calories.
Intervention Type
Behavioral
Intervention Name(s)
intermittent fasting
Intervention Description
Women were required to fast for 16 hours and consume their allotted calories during the remaining 8 hours.
Intervention Type
Behavioral
Intervention Name(s)
Caloric restriction
Intervention Description
Daily caloric requirement was calculated using basal metabolic rate (BMR) calculator. All women were directed to decrease calorie intake by 500 calories.
Primary Outcome Measure Information:
Title
weight loss in kg
Time Frame
in 3 months
Secondary Outcome Measure Information:
Title
decrease in body fat percentage
Time Frame
in 3 months
Title
fasting plasma insulin
Time Frame
in 3 months
Title
blood pressure in mm Hg
Time Frame
in 3 months
10. Eligibility
Sex
Female
Gender Based
Yes
Gender Eligibility Description
females
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
35 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
PCOS as described by Rotterdam's criteria
Exclusion Criteria:
endocrine disorders
diabetic
hypertensive
Taking medications affecting weight or energy intake/energy expenditure in the last 6 months, including weight loss medications, antipsychotic drugs or other medications as determined by the study physician;
The body weight fluctuated more than 5% in recent 3 months.
Liver and kidney dysfunction: renal impairment, creatinine clearance rate < 30 mL/min/1.73 m2, transaminase increased, more than three times higher than the normal limit;
History of serious cardiovascular or cerebrovascular disease (angina, myocardial infarction or stroke) in the past 6 months;
History of thyroid diseases;
pregnant
Currently participating in weight loss programs or weight change in the past 3 months (> 5% current body weight)
Patients who cannot be followed for 16 months (due to a health situation or migration)
Patients who are unwilling or unable to give informed consent
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Rubina Izhar
Organizational Affiliation
Aziz Medical Center
Official's Role
Study Chair
Facility Information:
Facility Name
Aziz Medical Center
City
Karachi
State/Province
Sindh
ZIP/Postal Code
74600
Country
Pakistan
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Comparison of Intermittent Fasting and Caloric Deficit for Weight Loss in Women With Polycystic Ovarian Syndrome
We'll reach out to this number within 24 hrs